A telehealth founder has been sentenced for turning online mental health care into a massive Adderall pill mill that pushed over 37 million pills into American homes.
Story Snapshot
- Done Global founder Ruthia He gets six years in prison and a $1 million fine for a nationwide Adderall distribution and fraud scheme.
- Federal prosecutors say the company’s tech platform helped push more than 37 million Adderall pills and steal over $12 million from insurers.
- Clinical president David Brody personally prescribed hundreds of thousands of stimulant pills to patients he never evaluated, in what looked like “assembly line” medicine.
- The case highlights a wider federal crackdown on pandemic-era telehealth abuses and raises new questions about oversight, Big Tech style manipulation, and protecting families from online drug schemes.
Telehealth CEO Sentenced for Massive Adderall Scheme
Federal Judge Charles Breyer sentenced Done Global founder and former chief executive officer Ruthia He to six years in prison, plus a $1 million fine, for her role in a sweeping Adderall distribution and fraud scheme. Prosecutors said she used the company’s technology platform, pay structure, and clinical rules to unlawfully distribute more than 37 million Adderall pills to people across the country. The Justice Department called the operation a $90–$100 million scheme built on easy online access to powerful stimulants.
A federal jury in San Francisco had already convicted He in November 2025 on one count of conspiracy to distribute controlled substances, four counts of distribution of controlled substances, and one count of conspiracy to commit health care fraud. She was also convicted of conspiracy to obstruct justice, meaning jurors agreed she worked to interfere with the investigation once authorities started digging. The court found that Done Global’s practices went far beyond normal telehealth and crossed into criminal drug dealing and insurance fraud.
How Done Global Turned Telehealth into a Pill Mill
According to the Department of Justice, He and her team used a subscription-based website to promise fast, easy access to Adderall and other stimulants for a monthly fee. Court documents say they built the company to chase “billion‑dollar” tech valuations by targeting drug‑seeking customers and putting monthly revenue ahead of real medical care. Federal investigators say the company spent over $40 million on social media ads that pushed Americans, stuck at home during COVID, to believe they had attention deficit hyperactivity disorder.
Those ads drove people into a system that critics now compare to an assembly line. Prosecutors and regulators say Done Global set up clinical protocols that encouraged quick, rubber‑stamp prescribing instead of real evaluation and follow‑up. The New York Times reports that clinicians linked to the startup issued Adderall prescriptions at intervals as short as 30 seconds, suggesting many patients got life‑changing drugs after only a few clicks and a brief online visit. That kind of volume fits classic “pill mill” red flags seen in other telehealth fraud cases.
The Doctor Behind 394,000 Pills and $12 Million in Fraud
David Brody, Done Global’s former clinical president, was a key player. Prosecutors say he personally wrote prescriptions for 394,324 Schedule II stimulant pills for 6,559 Done members whom he never examined and whose charts he never reviewed. He was convicted alongside He on conspiracy and drug distribution charges and later sentenced to a shorter two‑year prison term and a $1 million fine. For a senior doctor, that pattern points to paperwork medicine, not genuine patient care.
Federal prosecutors and health officials say the company also lied to insurers to get the drugs paid for. Done Global staff submitted prior authorization forms claiming they followed standard diagnostic rules, used urine drug screens, and tried non‑stimulant treatments first, even when they had not. As a result, Medicare, Medicaid, and private insurers paid more than $12 million for Adderall and other stimulants they believed were properly prescribed. In the official case summary, the government puts total fraud‑linked payments even higher, at about $14 million.
What This Case Means for Families and the Telehealth Future
This case lands in the middle of a broader federal push to clean up pandemic‑era telehealth. When COVID hit, Washington relaxed rules so people could see doctors online and still get needed medicines, including some controlled substances. That flexibility helped many families, especially in rural areas, but also opened doors for bad actors. Federal agencies now say they have seen hundreds of millions of dollars in suspect billing, fake visits, and pill‑mill activity in the virtual care space.
Ruthia He, founder and former CEO of California-based digital mental health company Done Global Inc., was sentenced to six years in prison and fined $1 million for orchestrating a scheme that used the company's technology platform, compensation structure and clinical protocols to…
— The Washington Times (@WashTimes) July 8, 2026
For conservative families, the Done Global story touches several deep concerns at once: Big Tech‑style manipulation, weak safeguards, and government having to step in after the damage is done. He’s background in major tech firms and her use of aggressive, emotional advertising to push mind‑altering drugs shows how quickly “innovation” can turn into exploitation. At the same time, this Trump‑era Justice Department case shows that strong law enforcement, clear rules, and real accountability are still vital to protect children, workers, and vulnerable patients from online drug schemes dressed up as health care.
Sources:
townhall.com, wsj.com, fiercehealthcare.com, oig.hhs.gov, instagram.com, irs.gov, jamanetwork.com, swlaw.com, cms.gov
